Recommended Topic Related To:

Betaxolol Hydrochloride Ophthalmic

"Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss.

Uveitis occurs when "...

Betaxolol Hydrochloride Ophthalmic

CLINICAL PHARMACOLOGY

Betaxolol Hydrochloride HCl, a cardioselective (beta-1-adrenergic) receptor blocking agent, does not have significant membrane-stabilizing (local anesthetic) activity and is devoid of intrinsic sympathomimetic action. Orally administered beta-adrenergic blocking agents reduce cardiac output in healthy subjects and patients with heart disease. In patients with severe impairment of myocardial function, beta-adrenergic receptor antagonists may inhibit the sympathetic stimulatory effect necessary to maintain adequate cardiac function.

When instilled in the eye, Betaxolol Hydrochloride Ophthalmic Solution has the action of reducing elevated as well as normal intraocular pressure, whether or not accompanied by glaucoma. Ophthalmic betaxolol has minimal effect on pulmonary and cardiovascular parameters.

Ophthalmic betaxolol (one drop in each eye) was compared to timolol and placebo in a three-way crossover study challenging nine patients with reactive airway disease who were selected on the basis of having at least a 15% reduction in the forced expiratory volume in one second (FEV1) after administration of ophthalmic timolol. Betaxolol HCl had no significant effect on pulmonary function as measured by FEV1. Forced Vital Capacity (FVC) and FEV1/VC. Additionally, the action of isoproterenol, a beta stimulant, administered at the end of the study was not inhibited by ophthalmic betaxolol. In contrast, ophthalmic timolol significantly decreased these pulmonary functions.

FEV1 † Percent Change from Baseline1

 
Means
Betaxolol 1.0%a
Timolol 0.5%
Placebo
1.6
1.4
1.4
60 Minutes
2.3
-25.7*
5.8
120 Minutes
1.6
-27.4*
7.5
240 Minutes
-6.4
-26.9*
6.9
Isoproterenolb
36.1
-12.4*
42.8

1Schoene, R. B. et al., Am. J. Ophthal. 97:86, 1984.
aTwice the clinical concentration.
bInhaled at 240 minutes; measurement at 270 minutes.
*Timolol statistically different from betaxolol and placebo (p < 0.05).

No evidence of cardiovascular beta-adrenergic blockade during exercise was observed with betaxolol in a double-masked, three-way crossover study in 24 normal subjects comparing ophthalmic betaxolol, timolol and placebo for effect on blood pressure and heart rate. Mean arterial blood pressure was not affected by any treatment; however, ophthalmic timolol produced a significant decrease in the mean heart rate.

Mean Heart Rate1

 
TREATMENT
Betaxolol 1%a
Timolol 0.5%
Placebo
Minutes
0
79.2
79.3
81.2
2
130.2
126.0
130.4
4
133.4
128.0*
134.3
6
136.4
129.2*
137.9
8
139.8
131.8*
139.4
10
140.8
131.8*
141.3

1Atkins, J. M. et al., AM. J. Oph. 99:173-175, Feb., 1985.
aTwice the clinical concentration.
*Mean pulse rate significantly lower for timolol than betaxolol or placebo (p < 0.05).

CLINICAL STUDIES

Optic nerve head damage and visual field loss are the result of a sustained elevated intraocular pressure and poor ocular perfusion. Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) has the action of reducing elevated as well as normal intraocular pressure, and the mechanism of ocular hypotensive action appears to be a reduction of aqueous production as demonstrated by tonography and aqueous fluorophotometry. The onset of action with Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) can generally be noted within 30 minutes and the maximal effect can usually be detected 2 hours after topical administration. A single dose provides a 12-hour reduction in intraocular pressure. Clinical observation of glaucoma patients treated with Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) for up to three years shows that the intraocular pressure lowering effect is well maintained.

Clinical studies show that topical Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) reduces mean intraocular pressure 25% from baseline. In trials using 22 mmHg as a generally accepted index of intraocular pressure control, Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) was effective in more than 94% of the population studied, of which 73% were treated with the beta blocker alone. In controlled, double-masked studies, the magnitude and duration of the ocular hypotensive effect of Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) and ophthalmic timolol solution were clinically equivalent.

Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) has also been used successfully in glaucoma patients who have undergone a laser trabeculoplasty and have needed additional long-term ocular hypotensive therapy.

Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) has been well tolerated in glaucoma patients wearing hard or soft contact lenses and in aphakic patients.

Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) does not produce miosis or accommodative spasm which are frequently seen with miotic agents. The blurred vision and night blindness often associated with standard miotic therapy are not associated with Betaxolol Hydrochloride Ophthalmic Solution (betaxolol hydrochloride) . Thus, patients with central lenticular opacities avoid the visual impairment caused by a constricted pupil.

Last reviewed on RxList: 4/12/2006
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.

Related Drugs
Health Resources
Related Supplements
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations